TY  - JOUR
AU  - Mazur, Pawel K
AU  - Herner, Alexander
AU  - Mello, Stephano S
AU  - Wirth, Matthias
AU  - Hausmann, Simone
AU  - Sánchez-Rivera, Francisco J
AU  - Lofgren, Shane M
AU  - Kuschma, Timo
AU  - Hahn, Stephan A
AU  - Vangala, Deepak
AU  - Trajkovic-Arsic, Marija
AU  - Gupta, Aayush
AU  - Heid, Irina
AU  - Noël, Peter B
AU  - Braren, Rickmer
AU  - Erkan, Mert
AU  - Kleeff, Jörg
AU  - Sipos, Bence
AU  - Sayles, Leanne C
AU  - Heikenwälder, Mathias
AU  - Heßmann, Elisabeth
AU  - Ellenrieder, Volker
AU  - Esposito, Irene
AU  - Jacks, Tyler
AU  - Bradner, James E
AU  - Khatri, Purvesh
AU  - Sweet-Cordero, E Alejandro
AU  - Attardi, Laura D
AU  - Schmid, Roland M
AU  - Schneider, Guenter
AU  - Sage, Julien
AU  - Siveke, Jens
TI  - Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
JO  - Nature medicine
VL  - 30
IS  - 7
SN  - 1078-8956
CY  - New York, NY
PB  - Nature America Inc.
M1  - DKFZ-2024-01159
SP  - 2090
PY  - 2024
N1  - 2024 Jul;30(7):2090
AB  - Correction to: Nature Medicine https://doi.org/10.1038/nm.3952, published online 21 September 2015.In the originally published version of this article, there were errors in the histological sections depicted in Supplementary Figs. 4 and 10. Specifically:In Supplementary Fig. 4, the image of the Ki67 immunohistochemistry (IHC) for the Gemcitabine+JQ1 group was incorrect.In Supplementary Fig. 10, the pSTAT3 image for the IHC for the JQ1 group was incorrect.In Supplementary Fig. 10, Ki67 and MYC IHC images for JQ1 and JQ1+SAHA were swapped.
LB  - PUB:(DE-HGF)16
C6  - pmid:38816611
DO  - DOI:10.1038/s41591-024-03054-y
UR  - https://inrepo02.dkfz.de/record/290555
ER  -